Data & AI

AnalyticsIQ and Diaceutics Partner to Launch Breakthrough Healthcare Audience Targeting

Diaceutics x Doceree Partnership: Power Precision HCP Targeting with Real-Time Diagnostic and Genomic Data

Diaceutics and IQM Redefine HCP Marketing with Real-Time, AI-Powered Diagnostic Audiences

5 key highlights from Fierce Pharma Week 2026

Explore 5 key highlights from Fierce Pharma Week 2026, including timely HCP engagement, commercial applications of AI, omnichannel pharma marketing and patient engagement.

Precision for All: Watch the New Diaceutics Manifesto

Diaceutics empowers biopharma to enhance patient outcomes by providing data-driven solutions for diagnostic-driven therapies. Ensuring every eligible patient receives timely and  effective treatment.

Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

ASCO 2026 Trends to Watch: Precision Oncology, AI and Real-World Impact

Explore key trends in precision oncology, AI integration, and real-world impact at ASCO 2026, focusing on biomarker-driven therapies and actionable insights for improved patient outcomes.

Episode 8 The Pathology-Oncology Connection: Labs in Action

Explore how tailored testing and collaboration between labs and oncologists enhance diagnostic and treatment decisions in cancer care on the Better Testing, Better Treatment podcast.

Episode 7 Exploring Inherited Cancer: from clinic to lab

Discover how genetic testing for inherited cancer has evolved, transforming clinical practice and patient care, in episode 7 of the Better Testing, Better Treatment podcast.

Episode 6 Artificial Intelligence in Prostate Cancer: from clinic to lab

Discover how AI enhances prostate cancer diagnostics and treatment in our podcast featuring experts Pr. Sophie Ferlicot and Dr. Mario Terlizzi.

Episode 5 Oncogenic Fusion detection and reporting in NSCLC and solid tumors

Explore the latest insights on oncogenic fusion detection and reporting in NSCLC and solid tumors from experts Dr. Solomon and Dr. Saxena in this informative podcast episode.

Episode 4: Targeted therapies in cancer: From clinic to labs

Explore targeted cancer therapies from a European perspective in Episode 4 of the Better Testing, Better Treatment podcast, featuring insights from leading experts in the field.

Episode 3: Targeted therapies in Gastric cancer: From clinic to labs  

Explore targeted therapies in gastric cancer through insights from a pathologist and oncologist in this episode of the Better Testing, Better Treatment podcast series.

Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision

Engage healthcare professionals effectively with data-driven strategies that enhance treatment decisions and improve patient outcomes in this informative online webinar.

Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

Complexity to Clarity: Using Multi-Modal Data to drive commercial success

Watch our webinar to explore how a multi-modal data approach can simplify complexities in precision medicine and enhance commercialization strategies for better patient outcomes.

Current and anticipated future use of MRD in hematological and solid tumors​

This report explores the current and future use of minimal residual disease (MRD) testing, uncovering adoption trends, clinical applications, and commercial implications.